Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine 
Petrobras Posts Record Oil Exports as Production Surge Fuels Global Expansion 
AST SpaceMobile Joins MSCI ACWI Index as Largest New Addition, Boosting Market Visibility 
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal 
Russia Signals Further Restrictions on Telegram Amid Ongoing Regulatory Disputes 
Air New Zealand Cabin Crew Strike Set for February 12–13 Amid Failed Talks 
Canadian Airlines Suspend Cuba Flights Amid Jet Fuel Shortage and U.S. Sanctions 
CBA Shares Surge After Record Half-Year Profit as Rate Outlook Improves 
FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide 
Amazon Explores AI Content Marketplace With Media Publishers 
Trump Administration Plans Chip Tariff Exemptions for Big Tech Amid AI Data Center Push 
Macquarie Group Shares Jump as Third-Quarter Trading Conditions Improve Across Key Units 
U.S. Judge Allows Jeffrey Epstein Sex Trafficking Lawsuit Against Bank of America to Proceed 
ByteDance Advances AI Chip Development With Samsung Manufacturing Talks 
Boeing Reports Major Supply Chain Quality Improvements After Spirit AeroSystems Deal 
Treasury Wine Estates Shares Surge After U.S. Dispute Settlement and Earnings Upgrade 
Ralph Lauren Unveils Elegant Fall 2026 Women’s Collection Ahead of New York Fashion Week 
 of the December 22, 2017 Lead Plaintiff Deadline in the Class Action Alleging Improper Revenue Recognition Timing - EconoTimes)
SAN FRANCISCO, Nov. 13, 2017 -- Hagens Berman Sobol Shapiro LLP reminds investors in Skechers USA, Inc. (NYSE:SKX) of the December 22, 2017 Lead Plaintiff deadline in the securities class action alleging improper revenue recognition timing. If you purchased or otherwise acquired securities of SKX between April 23, 2015 and October 22, 2015 and suffered losses contact Hagens Berman Sobol Shapiro LLP. For more information visit:
https://www.hbsslaw.com/cases/SKX
or contact Reed Kathrein, who is leading the firm’s investigation, by calling 510-725-3000 or emailing
After the market closed on October 22, 2015, Defendants announced financial results for the third quarter ended September 30, 2015. The results included disappointing sales falling short of analysts’ estimates. According to Defendants, $20 million in net sales were shifted from Skechers’ third quarter 2015 into its second quarter 2015 due to early customer deliveries.
This news drove the price of Skechers shares down $14.55 to close at $31.64 on October 23, 2015 – a loss of over 31%.
“We’re focused on Skechers’s revenue recognition timing, whether it ran afoul of generally accepted accounting principles, and investors’ damages,” said Hagens Berman partner Reed Kathrein.
Whistleblowers: Persons with non-public information regarding Skechers should consider their options to help in the investigation or take advantage of the SEC whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 510-725-3000 or email [email protected].
About Hagens Berman
Hagens Berman is a national investor-rights law firm headquartered in Seattle, Washington with 70+ attorneys in 11 offices across the country. The firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the firm and its successes can be found at www.hbsslaw.com. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.
Contact:
Reed Kathrein, 510-725-3000
